Contents

Search


Estring

Indications: -> atrophic vaginitis Dosage: releases 7.5 ug/day of estradiol Adverse effects: -> little to no systemic effects -> no need for progestin to prevent endometrial hyperplasia Mechanism of action: -> vaginal ring that releases estradiol over 90 days

Related

Femring

General

vaginal ring hormone replacement therapy (HRT); estrogen replacement therapy; postmenopausal hormone replacement therapy

References

Prescriber's Letter 10(5):27 2003

Components

17-beta estradiol (E2, Estrace, Estinyl, Delestrogen, Elestrin, Evamist, Imvexxy)